CNTB
Connect Biopharma Holdings Ltd
NASDAQ: CNTB · HEALTHCARE · BIOTECHNOLOGY
$2.53
+5.42% today
Updated 2026-04-29
Market cap
$142.43M
P/E ratio
—
P/S ratio
2,225.53x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$1 – $4
Volume
0.3M
Connect Biopharma Holdings Ltd (CNTB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-90,741.00%
ROE
-82.70%
ROA
-46.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | — | — | — | — |
| 2019 | $0.00 | $-24.46M | — | — | — |
| 2020 | $0.00 | $-119.37M | — | — | — |
| 2021 | $0.00 | $-202.27M | — | — | — |
| 2022 | $0.00 | $-118.09M | — | — | — |
| 2023 | $0.00 | $-62.11M | — | — | — |
| 2024 | $26.03M | $-15.63M | 100.00% | -86.24% | -60.03% |
| 2025 | $64000.00 | $-55.48M | 100.00% | -90,740.63% | -86,687.50% |